Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lilja

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
Biomedica Biochimica Acta|January 1, 1991
Regulation of cystatin C activity by serine proteinasesM Abrahamson, D J Buttle, R W Mason, et al.
Journal of Internal Medicine|December 9, 2010
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screeningA Kjellman, O Akre, O Gustafsson, et al.
Transplantation|November 26, 1997
Fetal rat hepatocytes: isolation, characterization, and transplantation in the Nagase analbuminemic ratsH Lilja, N Arkadopoulos, P Blanc, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 5, 2001
Levels of dimethylarginines and cytokines in mild and severe preeclampsiaJ Ellis, U B Wennerholm, A Bengtsson, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissuesA Bjartell, A Paju, U H Stenman, et al.
The Journal of Urology|November 24, 1999
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomyH Lilja, A Haese, T Björk, et al.
BJU International|February 27, 2004
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in SwedenJ Hugosson, G Aus, S Bergdahl, et al.
Clinical Chemistry|July 1, 1996
Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serumT Piironen, J Lövgren, M Karp, et al.
British Journal of Cancer|April 11, 2013
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patientsZ Hagman, B S Haflidadóttir, J A Ceder, et al.
The Prostate|October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/mlA Haese, M Graefen, T Steuber, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Biomedica Biochimica Acta|January 1, 1991
Regulation of cystatin C activity by serine proteinasesM Abrahamson, D J Buttle, R W Mason, et al.
Journal of Internal Medicine|December 9, 2010
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screeningA Kjellman, O Akre, O Gustafsson, et al.
Transplantation|November 26, 1997
Fetal rat hepatocytes: isolation, characterization, and transplantation in the Nagase analbuminemic ratsH Lilja, N Arkadopoulos, P Blanc, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 5, 2001
Levels of dimethylarginines and cytokines in mild and severe preeclampsiaJ Ellis, U B Wennerholm, A Bengtsson, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissuesA Bjartell, A Paju, U H Stenman, et al.
The Journal of Urology|November 24, 1999
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomyH Lilja, A Haese, T Björk, et al.
BJU International|February 27, 2004
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in SwedenJ Hugosson, G Aus, S Bergdahl, et al.
Clinical Chemistry|July 1, 1996
Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serumT Piironen, J Lövgren, M Karp, et al.
British Journal of Cancer|April 11, 2013
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patientsZ Hagman, B S Haflidadóttir, J A Ceder, et al.
The Prostate|October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/mlA Haese, M Graefen, T Steuber, et al.
Pageof 19